Isaac Subirana - Genetic Mutations

Author Information

Isaac Subirana is a researcher affiliated with the Cardiovascular Epidemiology and Genetics Research Group at the Hospital del Mar Medical Research Institute (IMIM) in Barcelona, Spain. Additionally, he is part of the Consorcio CIBER, M.P. Epidemiología y Salud Pública (CIBERESP) at the Instituto de Salud Carlos III in Madrid, Spain.

Research Contributions

Isaac Subirana has made significant contributions to the field of cardiovascular epidemiology and genetics. His research encompasses various aspects of cardiovascular risk prediction, including the use of cardiac computed tomography and online risk calculators for heart failure. He has also investigated the prevalence of carotid atherosclerosis in HIV patients, the impact of inflammatory biomarkers on survival after endovascular repair of abdominal aortic aneurysms, and the association of calcitriol supplementation with COVID-19 mortality in chronic kidney disease patients. His work in DNA methylation biomarkers for myocardial infarction and cardiovascular disease is particularly noteworthy, reflecting his deep engagement in understanding and predicting cardiovascular health outcomes.

Aliases

Isaac Subirana is also known by the aliases I Subirana and I. Subirana.

Publication and Citation Metrics

Metric	Value
Citation Count	7355
h-index	41
Paper Count	200

Publications:

Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries)

DOI: 10.3390/jcm11030533

Year: 2022

Mortality Risk Prediction Dynamics After Heart Failure Treatment Optimization: Repeat Risk Assessment Using Online Risk Calculators

DOI: 10.3389/fcvm.2022.836451

Year: 2022

Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations

DOI: 10.1111/hiv.13093

Year: 2021

Improvement of cardiovascular risk prediction by longitudinal risk factor and competing risk data

DOI: 10.1093/EURJPC/ZWAB061.226

Year: 2021

Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-based Study

DOI: 10.20944/PREPRINTS202104.0173.V1

Year: 2021

Prognostic Value of Inflammatory Biomarkers in 5-Year Survival After Endovascular Repair of Abdominal Aortic Aneurysms in a Predominantly Male Cohort: Implications for Practice

DOI: 10.1007/s00268-021-06051-1

Year: 2021

Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population

DOI: 10.3390/jpm11111085

Year: 2021

Validity and trends of myocardial infarction incidence and case-fatality estimated from linked administrative databases

DOI: 10.1093/EURJPC/ZWAB061.440

Year: 2021

Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study

DOI: 10.3390/biomedicines9050509

Year: 2021

DNA methylation biomarkers of myocardial infarction and cardiovascular disease

DOI: 10.1186/s13148-021-01078-6

Year: 2021

How Can Genetic Counseling Help?

How Does Hemoglobin Electrophoresis Work?

What Treatments are Available for Delta F508 Mutation?

Can Genetic Testing Help in Identifying Asbestos-Related Risks?

Are Synonymous Codons Truly Silent?

How Does Radiation Cause Genetic Mutations?

What is Brain Development?

How Does Genetic Counseling Help?

What are Targeted Therapies?

How Can Harmful Mutations Be Managed or Treated?

Partnered Content Networks

Relevant Topics